These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11198599)

  • 1. Intraperitoneal administration of recombinant human growth hormone in children with end-stage renal disease.
    Gipson DS; Kausz AT; Striegel JE; Melvin TR; Astrom LJ; Watkins SL
    Pediatr Nephrol; 2001 Jan; 16(1):29-34. PubMed ID: 11198599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
    Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
    Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
    Iglesias P; Selgas R; Méndez J; Fernández-Reyes MJ; Bajo MA; Aguilera A; Díez JJ
    Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of growth failure with growth hormone in children with chronic kidney disease: an open-label long-term study.
    Müller-Wiefel D; Frisch H; Tulassay T; Bell L; Zadik Z
    Clin Nephrol; 2010 Aug; 74(2):97-105. PubMed ID: 20630129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.
    Bacchetta J; Wesseling-Perry K; Kuizon B; Pereira RC; Gales B; Wang HJ; Elashoff R; Salusky IB
    Clin J Am Soc Nephrol; 2013 May; 8(5):824-32. PubMed ID: 23559676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive dietary protein and suboptimal caloric intake have a negative effect on the growth of children with chronic renal disease before and during growth hormone therapy.
    Zadik Z; Frishberg Y; Drukker A; Blachar Y; Lotan D; Levi S; Reifen R
    Metabolism; 1998 Mar; 47(3):264-8. PubMed ID: 9500560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth hormone treatment before and after renal transplantation].
    Pasqualini T; Ferraris J
    Medicina (B Aires); 1998; 58(3):265-70. PubMed ID: 9713094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone--insulin-like growth factor-I (IGF-I) axis in prepubertal children with chronic renal failure.
    Ferraris J; Pasqualini T; Gutman R; Ramírez J; Fainstein-Day P
    J Pediatr Endocrinol Metab; 1997; 10(1):19-25. PubMed ID: 9364338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group.
    Fine RN; Brown DF; Kuntze J; Wooster P; Kohaut EE
    J Pediatr; 1996 Dec; 129(6):883-91. PubMed ID: 8969731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of recombinant human growth hormone (rhGH) following intraperitoneal instillation.
    Fine RN; Fine SE; Sherman BM
    Perit Dial Int; 1989; 9(2):91-3. PubMed ID: 2488206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.
    Calenda KA; Schornagel IL; Sadeghi-Nejad A; Grand RJ
    Inflamm Bowel Dis; 2005 May; 11(5):435-41. PubMed ID: 15867582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
    Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
    Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H; Rosilio M; Blum WF; Drop SL
    Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of IGF-1 in children born small for gestational age and with growth retardation, treated by growth hormone adapted to IGF-1 levels after 1 year.
    Cabrol S; Perin L; Colle M; Coutant R; Jésuran-Perelroizen M; Le Bouc Y; Czernichow P
    Horm Res Paediatr; 2011; 76(6):419-27. PubMed ID: 22156543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience--a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study.
    Mentser M; Breen TJ; Sullivan EK; Fine RN
    J Pediatr; 1997 Jul; 131(1 Pt 2):S20-4. PubMed ID: 9255222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.